VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V:CBW) ("Wheaton Income" or the "Company") is excited to launch KoLab Project Inc. (“KoLab Project”) (formerly RockGarden Medicinals (2014) Inc.). Upon receiving the necessary regulatory approvals, Kolab Project will offer an exclusive monthly subscription platform to authorized medical cannabis patients. The objective of KoLab Project is to rethink the patient experience for Canadians registered under the Access to Cannabis for Medical Purposes Regulations.



KoLab Project will collaborate with the best and brightest growers, licensed producers, creators, and artists to curate a unique monthly experience for Canadian patients. KoLab Project will source a diverse range of cannabis through Wheaton’s unparalleled industry network and provide patients with access to curated cannabis cultivated by select licensed producers and acclaimed guest growers from around the globe.

Andrew Rock, Chief Operating Officer of KoLab Project, stated, “We are excited to launch this initiative not only for us, but for patients across Canada. We believe that as the industry expands and gets busier, it will create a lot of noise and choice that will be daunting for a consumer to navigate. Our goal is to simplify this relationship by focusing on quality, innovation and collaboration within our networks to curate unique monthly experiences for Canadian patients. We look forward to working with a variety of collaborators from different industries to build this project into something that resonates and brings value for everyone involved. Our goal is not to be our patients’ only licensed producer, but to be their favourite!”

Ian Rapsey, Chief Creative Officer of Wheaton Income, stated, “As the industry leads up to adult recreational use, a lot bandwidth is being spent on scale and it would seem there are a few less stories on innovation and pushing the potential for the industry. The Wheaton team is focused on scale and readiness for summer 2018, but additionally our focus is to dovetail those strategies with pushing ourselves to think and try new things that move this industry forward in unexpected and delightful ways. Which is what makes our facility in Carleton Place so appealing. While it might not be big in stature, it overflows with the opportunity to do something different for the industry. KoLab Project will be a hub for innovation, a sandbox for collaboration and a brand that will be a benchmark for what’s possible within the industry.”

ON BEHALF OF THE BOARD

"Chuck Rifici" Chairman & CEO

About Wheaton Income. (TSX-V:CBW)

Wheaton Income is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

About KoLab Project

KoLab Project is Wheaton’s wholly-owned subsidiary and is licensed to cultivate cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations. KoLab project will offer a unique patient experience that will be curated on a monthly basis with collaboration with best and brightest growers, licensed producers, creators, and artists. For more information, please visit www.KoLabProject.com.

Stay Connected:

For more information about investing in Cannabis Wheaton, please visit: http://www.wheatonincome.com or contact our investor relations team at: 800.980.1314 or IR@wheatonincome.com. Follow up on Twitter @WheatonIncome.

Media Contact:

Sarah Bain, VP External Affairs

Email: sarah@cannabiswheaton.com

Phone: 613.230.5869

Forward-Looking Information

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: regulatory or political change, timeliness of government approvals for granting of permits and licences, including licences to sell cannabis, actual operating performance of the facilities, competition and other risks affecting the Company in particular and the cannabis industry generally. Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward -looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release